Erasca, Inc. (ERAS)
3.26
-0.04
(-1.21%)
USD |
NASDAQ |
Dec 10, 16:00
3.26
0.00 (0.00%)
After-Hours: 16:59
Erasca Total Assets (Quarterly): 420.40M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ALX Oncology Holdings, Inc. | 82.72M |
| Prelude Therapeutics, Inc. | 94.76M |
| Atea Pharmaceuticals, Inc. | 342.96M |
| Immuneering Corp. | 241.06M |
| ProKidney Corp. | 351.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 72.52M |
| Shareholders Equity (Quarterly) | 347.89M |
| Debt to Equity Ratio | 0.1388 |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | 0.18% |